The Company plans for its busiest exploration season to-date in 2025 targeting rare earth elements ("REE") and thorium ("Th") at its expansive land holdings in central Idaho
All three projects: Lemhi Pass, Mineral Hill, and Diamond Creek are included in the U.S.' National REE Inventory and located in Idaho's well-known and underexplored REE-Th Belt
IDR believes its projects are well suited for President Trump's recent Executive Order titled, "Immediate Measures to Increase American Mineral Production in the United States"
Read More
This investment harnesses artificial intelligence to deliver actionable insights for improving asset reliability, performance, and operational excellence across key process industries, including oil and gas, utilities, and cement.
Read More
Key Findings:
KOCH DLE Process achieves an average lithium recovery rate of 98%
Key brine contaminants average rejection greater than 99%, resulting in low purification production costs
Industry leading Lithium Chloride concentration attained
Li:TDS ratio of up to 0.129, averaging 0.126, significantly above the target Li:TDS of 0.08, expected to lower the cost with less evaporation during the EV battery grade purification process
43,500 gallons (165,000 litres) of high purity lithium chloride was produced that meet or exceeded the specifications required by downstream processors
The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in The Toronto-Dominion Bank (NYSE: TD) shares. Investors who purchased shares of The Toronto-Dominion Bank on the NYSE should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
Soft tissue injuries like UCL tears, hamstring pulls and oblique strains are more common early in the season, but non-invasive treatment technology, sam®Recover can help athletes recover faster and stay on the field.
Read MoreThe Shareholders Foundation, Inc. announced that a deadline is coming up on May 05, 2025 in the lawsuit that was filed for certain investors in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Investors in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
XMPro today announced Version 1.4 of its Multi-Agent Generative System (MAGS). This update strengthens industrial AI teams' ability to make better decisions in dynamic environments
Read MoreMarathon Bancorp, Inc. (the "Company") (OTC Pink: MBBC), the holding company for Marathon Bank (the "Bank"), announced today that the Company has extended the community offering to allow additional time to sell shares of its common stock.
Read MoreThe Shareholders Foundation, Inc. announced that a deadline is coming up on April 7, 2025, in the lawsuit that was filed for certain investors in shares of Neumora Therapeutics, Inc. (NASDAQ: NMRA). Investors in shares of Neumora Therapeutics, Inc. (NASDAQ: NMRA) should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
Former Payoneer CTO and Microsoft VP brings over two decades of expertise in enterprise security, scaling startups within enterprises, and driving strategic growth
Read MoreThe Shareholders Foundation, Inc. announced that a deadline is coming up on April 18, 2025 in the lawsuit that was filed for certain investors in shares of Venture Global, Inc. (NYSE: VG). Investors who purchased a significant amount of shares of Venture Global, Inc. (NYSE: VG) in the company's initial public offering ("IPO") have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read MoreStrategic acquisition expands MIRA's pipeline with SKNY-1, a next-generation oral therapeutic targeting the two leading causes of preventable death-obesity and smoking.
Read More
"This is insanity," declares Duane Boise, CEO of MMJ International Holdings, echoing the sentiments of lawmakers and researchers alike. The 2020 House Oversight Committee hearing, and ongoing developments, have laid bare the Drug Enforcement Administration's (DEA) persistent obstruction of legitimate cannabis research, a battle MMJ has been fighting since their 2018 application. Despite bipartisan congressional outrage, as highlighted by Representative Earl "Buddy" Carter's scathing critique of the DEA's "epitome of ineptitude," and the agency's own hollow defenses, the DEA, represented by figures like Matthew Strait and Thomas Prevoznik, continues to delay and deny, hindering vital medical advancements. Boise's lawsuit against the DEA underscores the urgent need for reform, as the agency's actions not only impede scientific progress but also deny patients access to potentially life-changing treatments, a situation that demands immediate structural changes in federal cannabis policy.
Read More
